The Cell-Factory

The Cell-Factory is a clinical-stage biotechnology company focused on the development of next-generation regenerative medicine therapies using Mesenchymal Stem Cell-derived Extracellular Vesicles (MSC-EVs), also known as exosomes. As the R&D arm of the Esperite Group, the company leverages its proprietary CF-MEV platform to produce standardized, off-the-shelf therapeutic products that aim to provide the anti-inflammatory and regenerative benefits of stem cells without the risks associated with live cell transplantation. Their lead programs target complex inflammatory conditions such as Crohn's perianal fistulas and neurological disorders including drug-resistant epilepsy. The company's technology emphasizes high-yield production and purification of exosomes for large-scale clinical applications.